FI962979A - Hirudiinia sisältävät farmaseuttiset koostumukset - Google Patents

Hirudiinia sisältävät farmaseuttiset koostumukset Download PDF

Info

Publication number
FI962979A
FI962979A FI962979A FI962979A FI962979A FI 962979 A FI962979 A FI 962979A FI 962979 A FI962979 A FI 962979A FI 962979 A FI962979 A FI 962979A FI 962979 A FI962979 A FI 962979A
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
compositions containing
containing hirudin
hirudin
sugar
Prior art date
Application number
FI962979A
Other languages
English (en)
Swedish (sv)
Other versions
FI962979A0 (fi
Inventor
Tudor Arvinte
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI962979A0 publication Critical patent/FI962979A0/fi
Publication of FI962979A publication Critical patent/FI962979A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • A61K38/58Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FI962979A 1994-01-26 1996-07-26 Hirudiinia sisältävät farmaseuttiset koostumukset FI962979A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9401447A GB9401447D0 (en) 1994-01-26 1994-01-26 Pharmaceutical compositions
PCT/IB1995/000053 WO1995020399A1 (en) 1994-01-26 1995-01-25 Pharmaceutical compositions comprising hirudin

Publications (2)

Publication Number Publication Date
FI962979A0 FI962979A0 (fi) 1996-07-26
FI962979A true FI962979A (fi) 1996-07-26

Family

ID=10749331

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962979A FI962979A (fi) 1994-01-26 1996-07-26 Hirudiinia sisältävät farmaseuttiset koostumukset

Country Status (20)

Country Link
US (1) US6436901B1 (fi)
EP (1) EP0758905B1 (fi)
JP (2) JP3260760B2 (fi)
AT (1) ATE201996T1 (fi)
AU (1) AU1391595A (fi)
CA (1) CA2181907A1 (fi)
DE (1) DE69521315T2 (fi)
DK (1) DK0758905T3 (fi)
ES (1) ES2159621T3 (fi)
FI (1) FI962979A (fi)
GB (1) GB9401447D0 (fi)
GR (1) GR3036574T3 (fi)
HU (1) HU214823B (fi)
IL (1) IL112388A0 (fi)
MX (1) MX9603010A (fi)
NO (1) NO963113L (fi)
NZ (1) NZ278433A (fi)
PT (1) PT758905E (fi)
WO (1) WO1995020399A1 (fi)
ZA (1) ZA95577B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
US6653062B1 (en) * 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
CA2433936A1 (en) * 2001-01-23 2002-08-22 Boston Scientific Corporation Localized myocardial injection method for treating ischemic myocardium
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
RS50510B (sr) 2004-10-29 2010-03-02 Pharma Mar S.A., Sociedad Unipersonal Formulacije koje sadrže ekteinascidin i disaharid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
CA1341414C (fr) 1984-03-27 2002-12-31 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE3438296A1 (de) 1984-04-18 1985-11-07 Hoechst Ag, 6230 Frankfurt Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
DE3445532A1 (de) 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3804600A1 (de) 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8817161D0 (en) * 1988-07-19 1988-08-24 Ciba Geigy Ag Modified proteins
IT1243358B (it) 1990-07-23 1994-06-10 Iketon Farmaceutici Srl Composizioni farmaceutiche per la somministrazione orale di irudina
AU659432B2 (en) 1991-03-08 1995-05-18 Novartis Ag A method for the inhibition or prevention of tumor cell metastasis with hirudin
GB9303275D0 (en) 1993-02-18 1993-04-07 Ciba Geigy Ag Pharmaceutical compositions
GB9401448D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Stable dry powders

Also Published As

Publication number Publication date
MX9603010A (es) 1998-01-31
ZA95577B (en) 1995-07-26
CA2181907A1 (en) 1995-08-03
HUT74879A (en) 1997-02-28
FI962979A0 (fi) 1996-07-26
IL112388A0 (en) 1995-03-30
DE69521315T2 (de) 2001-10-31
ATE201996T1 (de) 2001-06-15
AU1391595A (en) 1995-08-15
EP0758905B1 (en) 2001-06-13
GB9401447D0 (en) 1994-03-23
DK0758905T3 (da) 2001-09-03
US6436901B1 (en) 2002-08-20
ES2159621T3 (es) 2001-10-16
NZ278433A (en) 1997-03-24
GR3036574T3 (en) 2001-12-31
WO1995020399A1 (en) 1995-08-03
HU214823B (hu) 1998-06-29
NO963113D0 (no) 1996-07-25
JPH09508377A (ja) 1997-08-26
DE69521315D1 (de) 2001-07-19
JP2001026548A (ja) 2001-01-30
PT758905E (pt) 2001-11-30
EP0758905A1 (en) 1997-02-26
JP3260760B2 (ja) 2002-02-25
HU9602037D0 (en) 1996-09-30
NO963113L (no) 1996-09-17

Similar Documents

Publication Publication Date Title
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
IS4565A (is) 2-methýl-thíenó-bensódíasepín, samsetning til inntöku
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
PT1112266E (pt) 4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem.
DE68913693D1 (de) Aerosol-Zusammensetzung.
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
ITRM940002A0 (it) Composizione orale.
NO20012727L (no) 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme
FI962979A (fi) Hirudiinia sisältävät farmaseuttiset koostumukset
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
BR9709406B1 (pt) fluorenonas alquiloxiamino substituìdas e composição farmacêutica contendo as mesmas.
IT1272208B (it) Composizioni pesticide.
IT8522359A0 (it) Composizioni farmaceutiche che li derivati di vitamina d,contengono e loro precursori.
FI851134A0 (fi) Farmaceutisk komposition, som innehaoller tetracyklin- eller doxicyklinsalter och foerfarande foer framstaellning av en saodan komposition.
ITRM940378A0 (it) Composizioni erbicide.
TR27743A (tr) Sulu, akici fenazakin bilesimi.
DE68912215D1 (de) Aerosolzusammensetzung.
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
SE8503513L (sv) Farmaceutiska och kosmetiska kompositioner, vilka som verksam bestandsdel innehaller acetyl-10-triacetoxi-1,8,9-antracen
FR2701395B1 (fr) Composition parfumante.
IT1267343B1 (it) Composizione insetticida.
DE68902758D1 (de) Entlackungsmittel-zusammensetzung.
ITFI930007A0 (it) Tiodiazepine, loro processidi preparazione e composizioni farmaceuti- che che le contengono.
NO901897D0 (no) Sammensetninger som inneholder aktivt svovel.
FI931345A0 (fi) Tjuvalarm, som aktiveras av foeremaolets, som skall skyddas, roerelse

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG